Publication | Open Access
In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species
124
Citations
0
References
1996
Year
Candida SppMedicinal FungiClinical MycologyAntimicrobial ChemotherapyDrug ResistanceVaginitisCandida SpeciesNew Triazole DerivativeAntimicrobial ResistanceHealth SciencesAntifungal AgentsTriazole Antifungal AgentsAntimicrobial CompoundLow ConcentrationsPharmacologyClinical MicrobiologyFungal PathogenAntifungal AgentVitro StudiesMicrobiologyMedicine
A new triazole derivative (voriconazole or UK-109,496) and fluconazole were tested against 249 isolates of Candida spp. representing six species. Voriconazole was 10 to 100 times more potent than fluconazole. Strains with decreased susceptibility to fluconazole were inhibited by relatively low concentrations of voriconazole.